HBV DRUG RESISTANCE

The HBV Drug Resistance test identifies mutations in the hepatitis B virus that may confer resistance to antiviral drugs. This test is essential for guiding treatment decisions and optimizing therapy in patients with chronic HBV. Early detection of resistance ensures better management of the infection.

Also known asHbv Drug Resistance Hbv Drug Resistance

Available via

Home Collection, Lab Visit

Contains

6 parameters

Earliest reports in

5 Working Days

Test details

HBV DRUG RESISTANCE Test in Vadodara Overview

Preparations

No special preparations needed

Test included
HBV DRUG RESISTANCE includes 6 parameters

  • Preliminary Report
  • Lamivudine Resistance
  • Telbivudine Resistance
  • Adefovir Resistance
  • Tenofovir Resistance
  • Entecavir Resistance
Frequently Asked Questions

This test analyzes the genetic sequence of the hepatitis B virus (HBV) to detect mutations associated with resistance to antiviral medications.

It is used in patients with chronic HBV who are not responding to treatment or who are undergoing long-term antiviral therapy. It helps in adjusting the treatment strategy.

A blood sample is taken, and HBV DNA is extracted and sequenced to identify mutations related to drug resistance.

The presence of resistance mutations suggests that current antiviral medications may be ineffective. The results guide changes in therapy to more effective drugs.

No special preparation is needed, though clinical history and prior treatments should be shared with the lab.

Test code

RD1305

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Plasma EdtaLavender Vacutainer1 ML
SerumYellow Vacutainer1 ML

Specimen stability information

Plasma Edta, Serum

Specimen rejection criteria

Test run frequency

Wednesday TIME - 10:00

Turn around time

5 Working Days

Performing locations

Department

  • Molecular Biology

CPT and Loinc codes

HBV DRUG RESISTANCE

8200